KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $11.03 $12.67 Friday, 26th Apr 2024 DVAX stock ended at $11.21. This is 0.358% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.09% from a day low at $11.03 to a day high of $11.26.
90 days $11.03 $13.41
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Jan 11, 2022 $14.48 $14.84 $14.03 $14.19 1 365 800
Jan 10, 2022 $13.66 $14.48 $13.15 $14.44 2 543 900
Jan 07, 2022 $13.12 $13.83 $13.06 $13.52 1 812 900
Jan 06, 2022 $13.18 $14.12 $12.90 $13.11 3 051 300
Jan 05, 2022 $13.40 $13.71 $12.56 $12.61 1 760 300
Jan 04, 2022 $13.97 $13.97 $12.94 $13.40 1 889 828
Jan 03, 2022 $14.24 $14.25 $13.44 $13.88 1 426 839
Dec 31, 2021 $14.22 $14.30 $13.90 $14.07 1 147 967
Dec 30, 2021 $14.91 $15.30 $14.12 $14.22 1 641 211
Dec 29, 2021 $14.42 $15.05 $14.30 $15.00 1 631 270
Dec 28, 2021 $14.23 $15.13 $14.19 $14.20 2 212 430
Dec 27, 2021 $14.24 $14.60 $13.95 $14.39 1 331 787
Dec 23, 2021 $14.04 $14.27 $13.53 $14.15 1 321 315
Dec 22, 2021 $13.86 $14.22 $13.65 $14.04 1 155 277
Dec 21, 2021 $14.23 $14.34 $13.75 $14.23 1 697 909
Dec 20, 2021 $15.19 $15.28 $14.03 $14.14 2 579 221
Dec 17, 2021 $14.09 $15.25 $14.02 $15.19 4 363 340
Dec 16, 2021 $14.31 $14.82 $13.96 $14.16 1 586 831
Dec 15, 2021 $13.52 $14.24 $13.20 $14.15 1 485 995
Dec 14, 2021 $13.07 $13.56 $12.97 $13.38 1 168 609
Dec 13, 2021 $13.44 $13.97 $13.08 $13.21 1 241 516
Dec 10, 2021 $13.65 $13.98 $13.17 $13.33 2 455 759
Dec 09, 2021 $14.38 $14.50 $13.68 $13.70 1 263 256
Dec 08, 2021 $14.42 $14.72 $14.18 $14.35 1 391 103
Dec 07, 2021 $13.70 $14.72 $13.70 $14.45 2 158 013
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT